Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma

por van Vliet, Amanda A., Georgoudaki, Anna-Maria, Raimo, Monica, de Gruijl, Tanja D., Spanholtz, Jan
Publicado 2021

Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34(+) progenitor cell-derived NK cells

por van Vliet, Amanda A., Peters, Ella, Vodegel, Denise, Steenmans, Daniëlle, Raimo, Monica, Gibbs, Susan, de Gruijl, Tanja D., Duru, Adil D., Spanholtz, Jan, Georgoudaki, Anna-Maria
Publicado 2023

Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90

por Saha, Tanmoy, van Vliet, Amanda A., Cui, Chunxiao, Macias, Jorge Jimenez, Kulkarni, Arpita, Pham, Luu Nhat, Lawler, Sean, Spanholtz, Jan, Georgoudaki, Anna-Maria, Duru, Adil Doganay, Goldman, Aaron
Publicado 2021

Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor

por Toffoli, Elisa C., Sheikhi, Abdolkarim, Lameris, Roeland, King, Lisa A., van Vliet, Amanda, Walcheck, Bruce, Verheul, Henk M. W., Spanholtz, Jan, Tuynman, Jurriaan, de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado 2021